Deciphera Pharmaceuticals Inc (DCPH) Return on Investment ROI from the first quarter of 2024 to first quarter of 2023 and for the year 2024, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Deciphera Pharmaceuticals Inc   (NASDAQ: DCPH)


Deciphera Pharmaceuticals Inc's ROI from its first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Deciphera Pharmaceuticals Inc's ROI in the first quarter of 2024?
Deciphera Pharmaceuticals Inc recorded a cumulative net loss of $-190 million during 12 months ending in the first quarter of 2024, resulting in a negative return on investment (ROI) of -52.42%.

Within the Healthcare sector 556 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2023 from 3252 to 4101.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Investment Change TTM -6.89 % 13.29 % 15.7 % 14.56 % 11.2 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 316 351 382 404 440
Return On Investment (TTM) -52.42 % -49.44 % -49.41 % -47.99 % -46.56 %
DCPH's Overall Ranking # 4101 # 3252 # 3827 # 3914 # 737
Seq. Investment Change TTM -7.86 % 0.59 % 0.51 % -0.04 % 12.11 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -190 -195 -194 -187 -182

DCPH Company Profile >> Back to DCPH Roi Comparisons >> See Annual DCPH Return On Investment



Return On Investment DCPH's Ranking
Within: No.
Industry # 242
Sector # 557
Overall # 4101

Return On Investment Statistics
High Average Low
-14.08 %
-42.7 %
-75.46 %
(Dec 31 2017)   (Mar 31 2022)







Financial Statements
Deciphera Pharmaceuticals Inc's I. Quarter Investments $ 316 Millions DCPH's Balance sheet
Deciphera Pharmaceuticals Inc's I. Quarter Income $ -45 Millions Quarterly DCPH's Income Statement
DCPH's Income by Division See DCPH's Income by Division


DCPH Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 351 342 305 544 546
Y / Y Investment Growth 2.7 % 12.13 % -43.95 % -0.51 % 611.06 %
Net Income in Millions -195 -179 -300 -266 -192
Y / Y Net Income Growth - - - - -
Annual Return On Investment -55.55 % -52.37 % -98.44 % -49.02 % -35.18 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DCPH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DCPH's Competitors
Subscribers only: Roi for Deciphera Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for DCPH's Customers

Other Ratios
DCPH's Roa DCPH's Inventory Turnover Ratio DCPH's Growth Rates DCPH's Dividend Statistics
DCPH's Profitability Ratios DCPH's Asset Turnover Ratio DCPH's Dividend Growth
DCPH's Roe DCPH's Valuation Ratios DCPH's Financial Strength Ratios DCPH's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector ROI

Date modified: 2026-09-26T07:32:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.